ArticleInternational journal of pharmaceutics2022

An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.

Fu-Fei Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.